Calcium channel blockers and hypertension: Evolving perspectives?1996-Reference-Cited by-同舟云学术

Calcium channel blockers and hypertension: Evolving perspectives?1996

Published:1997-01 Issue:S3 Volume:10 Page:883-891
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drug Ther

Author:

Epstein Murray

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00051616.pdf

Reference50 articles.

1. Triggle DJ. Biochemical and pharmacologic differences among calcium channel antagonists: Clinical implications. In: Epstein M, ed. Calcium Antagonists in Clinical Medicine. Philadelphia: Hanley & Belfus, 1992:1?27.

2. Ram JL, Standley PR, Sowers JR. Calcium function in vascular smooth muscle and its relationship to hypertension. In: Epstein M, ed. Calcium Antagonists in Clinical Medicine. Philadelphia: Hanley & Belfus, 1992:29?48.

3. Epstein M. CCBs in the management of hypertension. In: Epstein M, ed. Calcium Antagonists in Clinical Medicine. Philadelphia: Hanley & Belfus, 1992:213?230.

4. Loutzenhiser R, Epstein M. Calcium antagonists and the kidney. Hosp Pract 1987;22:63?76.

5. Epstein M. CCBs and renal protection: Current status and future perspectives. Arch Intern Med 1992;152:1573?1584.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiologic therapeutic targets in hypertension: a cardiological point of view;Expert Opinion on Therapeutic Targets;2012-01-27

2. Combination therapy with renin-angiotensin system blockers: Will amlodipine replace hydrochlorothiazide?;Current Hypertension Reports;2007-07-22

3. Safety and Efficacy of Therapeutically Equivalent Doses of Sustained-Release Formulations of Isradipine and Felodipine;Congestive Heart Failure;2003-11

4. Antihypertensive effects of six calcium antagonists: evidence from Fourier analysis of 24-hour ambulatory blood pressure recordings;Current Therapeutic Research;2001-04

5. Alpha-adrenergic blocking drugs in the management of benign prostatic hyperplasia: interactions with antihypertensive therapy;Urology;1999-03